Fig. 2From: Prediction of sensitivity to gefitinib/erlotinib for EGFR mutations in NSCLC based on structural interaction fingerprints and multilinear principal component analysisIFP matrices for four EGFR mutant-gefitinib complexes. a delE746_A750-gefitinib. b T790Â M_delE746_A750-gefitinib. c A763_Y764insFQEA-gefitinib. d D770_N771insSVD-gefitinibBack to article page